ZNF664 and coronary artery disorder: A methylation site within ZNF664 was associated with higher HDL levels (β = 0.03, P = 9.4e−11), lower risk for obesity (β = −0.013, P = 3.5e−16) and CAD (β = −0.02, P = 2.5e−5).